NDC 50419-540-06
Kerendia 10 mg/1
finerenone · TABLET, FILM COATED
Kerendia (finerenone) is a prescription tablet taken by mouth that belongs to a class of medications called nonsteroidal mineralocorticoid-receptor antagonists, used to treat chronic kidney disease in patients with type 2 diabetes. It works by blocking certain receptors in the body to help protect the kidneys from further damage.
Key Facts
- Brand Name
- Kerendia
- Generic Name
- finerenone
- NDC Code (Package)
50419-540-06- NDC Code (Product)
50419-540- Manufacturer
- Bayer HealthCare Pharmaceuticals Inc.
- Strength
- 10 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA215341
- Drug Class
- Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]
- Marketing Start
- 07/09/2021
Recall History
No Recall HistoryView Full Drug Page
Kerendia — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.